Arie Belldegrun, Chairman, President and CEO at Kite Pharma, Inc. (KITE), sold 6,986 shares at $50.86 ($355K) on 2016-12-20, disclosed to the SEC on 2016-12-22.
Open-market sale of $355k KITE by Chairman, President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.86 | 3,493 | $178K | 50.0% |
| 2 | $50.86 | 3,493 | $178K | 50.0% |
| Total | $50.86 avg | 6,986 | $355K | 100% |
| Filing → |
| ALLO | BUY | 2020-06-04 | $6.9M | — | Filing → |
| ALLO | BUY | 2019-02-13 | $3.5M | — | Filing → |
| KITE | SELL | 2017-09-27 | $9.5M | — | Filing → |